PROpatient: Can symptom monitoring and care coordination improve the quality of life of people with upper gastrointestinal cancer.

Not Applicable

• Conditions: pancreatic cancer; esophageal cancer; gastric cancer; Cancer - Pancreatic; Cancer - Oesophageal (gullet); Cancer - Stomach

• Registration Number: ACTRN12619001126101
• Lead Sponsor: Monash University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-08-12
• Last Update Posted: 3 February 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 246

Inclusion Criteria

Patients participating in the Upper Gastrointestinal Cancer Registry, who are newly diagnosed (up to 3 months post-diagnosis) with pancreatic, oesophageal and gastric cancer that are diagnosed, managed or treated at one of the participating trial sites.

Exclusion Criteria

Participants who do not meet the inclusion criteria, require an interpreter (non-English speaking), or without the capacity to give informed consent (suffering from dementia, delirium or confusion), will be excluded from the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified